Riken Vitamin Co., Ltd. (TYO:4526)
Japan
· Delayed Price · Currency is JPY 2,582.00
-18.00 (-0.69%)
Jun 9, 2025, 1:38 PM JST
Riken Vitamin Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 95,582 | 91,484 | 88,750 | 79,231 | 77,722 | Upgrade
|
| Revenue Growth (YoY) | 4.48% | 3.08% | 12.01% | 1.94% | -6.33% | Upgrade
|
| Cost of Revenue | 64,312 | 61,598 | 61,506 | 53,666 | 55,711 | Upgrade
|
| Gross Profit | 31,270 | 29,886 | 27,244 | 25,565 | 22,011 | Upgrade
|
| Selling, General & Admin | 22,545 | 16,941 | 16,638 | 16,007 | 17,268 | Upgrade
|
| Research & Development | - | 3,315 | 3,220 | 2,992 | 3,094 | Upgrade
|
| Operating Expenses | 22,545 | 20,514 | 20,117 | 19,723 | 20,643 | Upgrade
|
| Operating Income | 8,725 | 9,372 | 7,127 | 5,842 | 1,368 | Upgrade
|
| Interest Expense | -123 | -112 | -132 | -178 | -665 | Upgrade
|
| Interest & Investment Income | 874 | 671 | 536 | 448 | 416 | Upgrade
|
| Currency Exchange Gain (Loss) | -230 | 267 | 42 | 82 | 513 | Upgrade
|
| Other Non Operating Income (Expenses) | 166 | 96 | 150 | 102 | 252 | Upgrade
|
| EBT Excluding Unusual Items | 9,412 | 10,294 | 7,723 | 6,296 | 1,884 | Upgrade
|
| Merger & Restructuring Charges | -190 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 4,055 | 2,090 | 184 | 14,127 | 303 | Upgrade
|
| Gain (Loss) on Sale of Assets | 295 | 3 | - | - | -4 | Upgrade
|
| Asset Writedown | -212 | -558 | -57 | -174 | -359 | Upgrade
|
| Other Unusual Items | -684 | 78 | 7 | 64 | -1,831 | Upgrade
|
| Pretax Income | 12,704 | 11,907 | 7,857 | 20,313 | -7 | Upgrade
|
| Income Tax Expense | 3,313 | 3,149 | 1,440 | -1,285 | 1,603 | Upgrade
|
| Earnings From Continuing Operations | 9,391 | 8,758 | 6,417 | 21,598 | -1,610 | Upgrade
|
| Minority Interest in Earnings | -3 | -3 | -3 | -16 | -8 | Upgrade
|
| Net Income | 9,388 | 8,755 | 6,414 | 21,582 | -1,618 | Upgrade
|
| Net Income to Common | 9,388 | 8,755 | 6,414 | 21,582 | -1,618 | Upgrade
|
| Net Income Growth | 7.23% | 36.50% | -70.28% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 30 | 33 | 33 | 33 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 33 | 33 | 33 | 33 | Upgrade
|
| Shares Change (YoY) | -7.17% | -0.58% | 0.02% | 0.02% | 0.02% | Upgrade
|
| EPS (Basic) | 310.06 | 268.42 | 195.51 | 657.99 | -49.34 | Upgrade
|
| EPS (Diluted) | 310.06 | 268.42 | 195.51 | 657.99 | -49.34 | Upgrade
|
| EPS Growth | 15.51% | 37.29% | -70.29% | - | - | Upgrade
|
| Free Cash Flow | 3,214 | 7,915 | 5,723 | 3,573 | 3,928 | Upgrade
|
| Free Cash Flow Per Share | 106.15 | 242.66 | 174.45 | 108.93 | 119.78 | Upgrade
|
| Dividend Per Share | 94.000 | 81.000 | 59.000 | 46.000 | 42.000 | Upgrade
|
| Dividend Growth | 16.05% | 37.29% | 28.26% | 9.52% | - | Upgrade
|
| Gross Margin | 32.71% | 32.67% | 30.70% | 32.27% | 28.32% | Upgrade
|
| Operating Margin | 9.13% | 10.24% | 8.03% | 7.37% | 1.76% | Upgrade
|
| Profit Margin | 9.82% | 9.57% | 7.23% | 27.24% | -2.08% | Upgrade
|
| Free Cash Flow Margin | 3.36% | 8.65% | 6.45% | 4.51% | 5.05% | Upgrade
|
| EBITDA | 11,929 | 12,702 | 10,845 | 9,578 | 5,323 | Upgrade
|
| EBITDA Margin | 12.48% | 13.88% | 12.22% | 12.09% | 6.85% | Upgrade
|
| D&A For EBITDA | 3,204 | 3,330 | 3,718 | 3,736 | 3,955 | Upgrade
|
| EBIT | 8,725 | 9,372 | 7,127 | 5,842 | 1,368 | Upgrade
|
| EBIT Margin | 9.13% | 10.24% | 8.03% | 7.37% | 1.76% | Upgrade
|
| Effective Tax Rate | 26.08% | 26.45% | 18.33% | - | - | Upgrade
|
| Advertising Expenses | - | 964 | 1,204 | 1,460 | 2,762 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.